EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging Technologies in Cardiovascular Disease Modeling: Bridging Basic Science and Clinical Translation

Ramcharan Singh Angom iD, Sophie K Ashbrook iD, Carter Magnano iD, Riya Kar, Anya Dorairaj, Hari Krishnareddy Rachamala, Debabrata Mukhopadhyay iD

Cells · 2026

DOI: 10.3390/cells15191754 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2026. Verfasst von Ramcharan Singh Angom und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Molecular Biology, Mayo Clinic College of Medicine and Sciences, Jacksonville, FL 32224, USA. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Translational Research, Biomedical, Models, Biological. Die Arbeit nennt 298 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart Lung and Blood Institute, NHLBI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular diseases (CVDs) remain the leading cause of death worldwide, yet therapeutic development is limited by experimental models that incompletely recapitulate human physiology, disease heterogeneity, and treatment responses. Emerging human-relevant models, including patient-derived induced pluripotent stem cells, cardiac organoids, engineered tissues, organ-on-chip systems, genome editing, multi-omics, and computational approaches, are improving the ability to investigate cardiovascular disease mechanisms and therapeutic responses. In this review, we critically compare these technologies with respect to physiological relevance, reproducibility, scalability, throughput, and translational potential. We highlight their applications in disease modeling, drug discovery, toxicity assessment, and precision medicine while examining persistent limitations, including cellular immaturity, incomplete vascularization and systemic integration, model variability, and limited clinical validation. We further discuss how integration of bioengineering, genome editing, multi-omics, and computational methods may improve predictive performance. Standardization, interlaboratory validation, regulatory qualification, and prospective benchmarking against human clinical outcomes will be essential for translating these platforms into reliable tools for cardiovascular research and therapeutic development. Collectively, the convergence of stem cell biology, bioengineering, genome editing, multi-omics, and computational approaches is establishing a new generation of human-centered cardiovascular models with the potential to strengthen mechanistic discovery and accelerate the development of more predictive and personalized therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesTranslational Research, BiomedicalModels, BiologicalHumansAnimalsMultiomicsPrecision MedicineGene EditingInduced Pluripotent Stem CellsMicrophysiological Systems

Stichwörter der Autor:innen

CRISPR genome editingartificial intelligencecardiac organoidscardiovascular disease modelinghuman induced pluripotent stem cellsmulti-omicsorgan-on-chipprecision medicinetissue engineering

Autor:innen und Institutionen

  • Department of Biochemistry & Molecular Biology, Mayo Clinic College of Medicine and Sciences, Jacksonville, FL 32224, USA.
  • Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

ORCID-Profile: Ramcharan Singh Angom, Sophie K Ashbrook, Carter Magnano, Debabrata Mukhopadhyay

Förderung

  • NHLBI NIH HHS
  • National Heart Lung and Blood Institute
  • NHLBI
  • Florida Department of Health DeSantis

Zitieren

APA

Angom, R. S., Ashbrook, S. K., Magnano, C., Kar, R., Dorairaj, A., Rachamala, H. K., & Mukhopadhyay, D. (2026). Emerging Technologies in Cardiovascular Disease Modeling: Bridging Basic Science and Clinical Translation. Cells. https://doi.org/10.3390/cells15191754

Vancouver

Angom RS, Ashbrook SK, Magnano C, Kar R, Dorairaj A, Rachamala HK, et al. Emerging Technologies in Cardiovascular Disease Modeling: Bridging Basic Science and Clinical Translation. Cells. 2026. doi:10.3390/cells15191754

BibTeX
@article{Angom2026,
  author = {Angom, Ramcharan Singh and Ashbrook, Sophie K and Magnano, Carter and Kar, Riya and Dorairaj, Anya and Rachamala, Hari Krishnareddy and Mukhopadhyay, Debabrata},
  title = {Emerging Technologies in Cardiovascular Disease Modeling: Bridging Basic Science and Clinical Translation},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15191754}
}
Kostenlos starten →